Consensus Skye Bioscience, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 19:55:42 26/06/2024 BST			5-day change	1st Jan Change
8.035 ^USD	+1.97%		-12.88%	+186.03%

06-24	Skye Bioscience, Inc.(NasdaqGM:SKYE) added to S&P TMI Index	CI
06-10	Skye Bioscience, Inc. Concentrates Strategy and Clinical Development Focus on Nimacimab Metabolic Program	CI

c1fa8d9dd.6FFjlHqZIT_F9Arzi-WWp-TtblIa_tjhSb4ceWdrZGU.qhgX_E2ueEyjpU2F8pzD-IOsOmR_pOioJNRWMSg4KAGrMzrGOdh1dvaePg~057381b298de1b2fe7fe79767cf8596d

03-14

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

7.88 USD

Average target price

18.33 USD

Spread / Average Target

+132.66%

High Price Target

21 USD

Spread / Highest target

+166.50%

Low Price Target

14 USD

Spread / Lowest Target

+77.66%

Piper Sandler